01 / Contract Profile
75F40120C00197 Federal Contract Award
Agency code 7524
EOI::DEFEND THE SPEND::EOI PARTIAL TERMINATION FOR CONVENIENCE NO-COST SETTLEMENT AGREEMENT
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75F40120C00197 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations-$457
FY 2026Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2020 | $277.0K | 1 | — |
| FY 2021 | $285.3K | 1 | +3.0% |
| FY 2022 | $293.8K | 2 | +3.0% |
| FY 2023 | $302.7K | 1 | +3.0% |
| FY 2024 | $311.7K | 2 | +3.0% |
| FY 2025 | $176.7K | 7 | −43.3% |
| FY 2026 | -$457 | 2 | −100.3% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | FOOD AND DRUG ADMINISTRATION | FDA OFFICE OF ACQ GRANT SVCS |
05 / Contractor
Who holds this federal contract?
ES SQUARED, LLC
UEI J5FXQUCBKTH6 · CAGE 51Y26
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541611 | ADMINISTRATIVE MANAGEMENT AND GENERAL MANAGEMENT CONSULTING SERVICES | $1.65M | 16 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| U099 | EDUCATION/TRAINING- OTHER | $1.65M | 16 | 100.0% |
08 / Place of Performance
Where is the work recorded?
GRAND PRAIRIE, DALLAS, TEXAS, UNITED STATES
ZIP 750511502
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Jun 3, 2026 | P00015 | -$457 | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| Mar 20, 2026 | P00014 | $0 | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| Dec 8, 2025 | P00013 | $0 | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| Jul 16, 2025 | P00012 | $176.7K | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| Jul 8, 2025 | P00011 | $0 | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| Apr 28, 2025 | P00010 | $0 | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| Apr 4, 2025 | P00009 | $0 | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| Feb 21, 2025 | P00008 | $0 | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| Jan 13, 2025 | P00007 | $0 | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| Sep 16, 2024 | P00006 | $311.7K | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| May 16, 2024 | P00005 | $0 | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| Apr 11, 2023 | P00004 | $302.7K | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| Oct 7, 2022 | P00003 | $0 | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| Aug 5, 2022 | P00002 | $293.8K | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
| Sep 14, 2021 | P00001 | $285.3K | FDA OFFICE OF ACQ GRANT SVCSOffice code 75F401 | 541611 | U099 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.